Purchase Order N0060415P3261

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. The delivery order has a ceiling value of $3,183.36 and a period of performance through March 28, 2024. This award is part of a larger...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a medication used to treat opioid overdose. The contract is a firm fixed price delivery order with a potential value of $1,591.68 and a completion date of February 22, 2024. No set-aside designation was used for this award....

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a pharmaceutical product, with a potential value of $1,658.00 and a completion date of January 23, 2024. The award does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to...

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,251.76, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a medication used to reverse opioid overdose. The contract has a firm fixed price pricing type and an ultimate completion date of November 21, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, with a completion date of March 4, 2024 and a potential value of $16,580.00. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...

This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $4,389.84 and a period of performance through August 5, 2022. There is no set-aside designation for this award. AmerisourceBergen Drug Corp is a leading pharmaceutical distributor that...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order, valued at $3,771.11, is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a medication used to reverse opioid overdose. The order has a performance period through March 27, 2024 and does not use any set-aside designation. Amerisourcebergen Drug Corp is the prime...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, with a potential value of $1,079.76 and a completion date of February 6, 2024. The order is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued...

This is a $2,912.40 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a pharmaceutical product, with a completion date of January 3, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, through its Corporate Office division, is a prime contractor that provides a range of...

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of Naloxone HCL 4 mg nasal spray, a critical medical product used for the treatment and prevention of opioid overdose. The contract has a total ceiling value of $2,857.51 and is structured as a Firm Fixed Price Delivery Order, with a completion date of May 2, 2023. The contract is not designated with any...